GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. annual/quarterly total liabilities history from 2010 to 2019. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- GT Biopharma, Inc. total liabilities for the quarter ending December 31, 2019 were 19.7M, a 635.57% increase year-over-year.
- GT Biopharma, Inc. total liabilities for 2019 were 19.7M, a 635.57% increase from 2017.
- GT Biopharma, Inc. total liabilities for 2017 were 2.7M, a 85.86% decrease from 2016.
- GT Biopharma, Inc. total liabilities for 2016 were 18.9M, a 62.57% decrease from 2015.
- GT Biopharma, Inc. total liabilities for 2015 were 50.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| GT Biopharma, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2019 | $20 |
| 2017 | $3 |
| 2016 | $19 |
| 2015 | $51 |
| 2014 | $30 |
| 2013 | $6 |
| 2012 | $7 |
| 2011 | $5 |
| 2010 | $6 |
| GT Biopharma, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2019-12-31 | $20 |
| 2017-12-31 | $3 |
| 2016-12-31 | $19 |
| 2015-12-31 | $51 |
| 2014-12-31 | $30 |
| 2013-12-31 | $6 |
| 2012-12-31 | $7 |
| 2011-12-31 | $5 |
| 2010-12-31 | $6 |
GT Biopharma, Inc. Total Liabilities — FAQ
GT Biopharma, Inc. (GTBP) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GTBP's total liabilities history?
The chart and table above show GT Biopharma, Inc.'s total liabilities by year and by quarter, including the growth rate.